WEST COLUMBIA, S.C. (WIS) - For the second time in 2022, a West Columbia based pharmaceutical company is issuing a recall.

On June 30, 2022, Nephron Sterile Compound Center in West Columbia voluntarily recalled for 37 products.

The FDA reasoning for the recall was listed as a, “Lack of Assurance of Sterility.” The drugs were intended for a nationwide distribution.

In total the second recall impacts 1,616,777 units. The full listing of impacted products can be found below.

In May the company issued a recall that impacted 2.1 million doses of medicine and equipment.

Lou Kennedy, Nephron Pharmaceuticals Corporation CEO & Owner sent the same statement she sent for the May recall, which reads:

“Out of an abundance of caution, Nephron is proactively cooperating with the Food and Drug Administration on a voluntary recall of a limited number of product lots. We do not take this lightly. While there has been no impact to patient safety, and there is no evidence of contamination, Nephron has decided in the interest of patients to proceed with this recall process. The company is prepared to provide the resources and information necessary to health care providers and patients to make certain they have anything they need and any questions answered. They remain our top priority.”

Kennedy told WIS: “This is not a new event. It is all part or the same voluntary recall process.”

FDA records label this recall as a separate event from the May recall.

A report obtained by WIS from the FDA showed multiple inspections between March 28, 2022 and April 20, 2022 that detailed some of the conditions before the previous recall.

Copyright 2022 WIS. All rights reserved.

Notice a spelling or grammar error in this article? Click or tap here to report it. Please include the article’s headline.